| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |